HopeStage
Back to all studies
CompletedNCT02613494

Glycopyrrolate or Hyoscine for Clozapine-Related Drooling

About this titleRead the official source — NCT02613494
Medication studyAges 18–65United KingdomSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Preston and 1 more locationSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 25, 2016
Recruitment status
Completed
Enrollment listed in the registry
29
Sponsor
Mersey Care NHS Trust
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United Kingdom
Age range
From 18 Years to 65 Years
Official registry ID
NCT02613494
Official title
Show the full official title

A Feasibility Study of Glycopyrrolate in Comparison to Hyoscine Hydrobromide and Placebo in the Treatment of Hypersalivation Induced by Clozapine

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Preston · Liverpool

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mersey Care NHS Trust, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Hyoscine and Glycopyrrolate.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies